87 related articles for article (PubMed ID: 38646651)
21. Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette-Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy.
Liu K; Peng J; Guo Y; Li Y; Qi X; Duan D; Li T; Li J; Niu Y; Han G; Zhao Y
ACS Nano; 2024 May; 18(18):11910-11920. PubMed ID: 38680054
[TBL] [Abstract][Full Text] [Related]
22. Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy.
Liang Z; Cui X; Yang L; Hu Q; Li D; Zhang X; Han L; Shi S; Shen Y; Zhao W; Ju Q; Deng X; Wu Y; Sheng W
Int J Pharm; 2021 Oct; 608():121091. PubMed ID: 34555477
[TBL] [Abstract][Full Text] [Related]
23. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q
J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151
[TBL] [Abstract][Full Text] [Related]
24. Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen Loading.
Zeng T; Zang W; Xiao H; Jiang Y; Lin S; Wang M; Li S; Li L; Li C; Lu C; Yang H
ACS Nano; 2023 Sep; 17(18):18114-18127. PubMed ID: 37695697
[TBL] [Abstract][Full Text] [Related]
25. Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
Berner F; Flatz L
Immunol Rev; 2023 Sep; 318(1):37-50. PubMed ID: 37548043
[TBL] [Abstract][Full Text] [Related]
26. An engineered influenza virus to deliver antigens for lung cancer vaccination.
Ji D; Zhang Y; Sun J; Zhang B; Ma W; Cheng B; Wang X; Li Y; Mu Y; Xu H; Wang Q; Zhang C; Xiao S; Zhang L; Zhou D
Nat Biotechnol; 2024 Mar; 42(3):518-528. PubMed ID: 37231262
[TBL] [Abstract][Full Text] [Related]
27. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Rojas LA; Sethna Z; Soares KC; Olcese C; Pang N; Patterson E; Lihm J; Ceglia N; Guasp P; Chu A; Yu R; Chandra AK; Waters T; Ruan J; Amisaki M; Zebboudj A; Odgerel Z; Payne G; Derhovanessian E; Müller F; Rhee I; Yadav M; Dobrin A; Sadelain M; Łuksza M; Cohen N; Tang L; Basturk O; Gönen M; Katz S; Do RK; Epstein AS; Momtaz P; Park W; Sugarman R; Varghese AM; Won E; Desai A; Wei AC; D'Angelica MI; Kingham TP; Mellman I; Merghoub T; Wolchok JD; Sahin U; Türeci Ö; Greenbaum BD; Jarnagin WR; Drebin J; O'Reilly EM; Balachandran VP
Nature; 2023 Jun; 618(7963):144-150. PubMed ID: 37165196
[TBL] [Abstract][Full Text] [Related]
28. Vaccine-like nanomedicine for cancer immunotherapy.
Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
[TBL] [Abstract][Full Text] [Related]
29. Anion-Coordination-Driven Assembly.
Liang L; Zhao W; Yang XJ; Wu B
Acc Chem Res; 2022 Nov; 55(22):3218-3229. PubMed ID: 36331808
[TBL] [Abstract][Full Text] [Related]
30. Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.
Liu L; Chen J; Zhang H; Ye J; Moore C; Lu C; Fang Y; Fu YX; Li B
Nat Cancer; 2022 Apr; 3(4):437-452. PubMed ID: 35393580
[TBL] [Abstract][Full Text] [Related]
31. Two-Pronged Intracellular Co-Delivery of Antigen and Adjuvant for Synergistic Cancer Immunotherapy.
Meng J; Zhang P; Chen Q; Wang Z; Gu Y; Ma J; Li W; Yang C; Qiao Y; Hou Y; Jing L; Wang Y; Gu Z; Zhu L; Xu H; Lu X; Gao M
Adv Mater; 2022 May; 34(21):e2202168. PubMed ID: 35362203
[TBL] [Abstract][Full Text] [Related]
32. Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle.
Li Q; Shi Z; Zhang F; Zeng W; Zhu D; Mei L
Acta Pharm Sin B; 2022 Jan; 12(1):107-134. PubMed ID: 35127375
[TBL] [Abstract][Full Text] [Related]
33. Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating
He Z; Jia H; Zheng M; Wang H; Yang W; Gao L; Zhang Z; Xue J; Xu B; Yang W; Xing G; Gao X; Gao F
ACS Appl Bio Mater; 2021 Jul; 4(7):5707-5716. PubMed ID: 35006752
[TBL] [Abstract][Full Text] [Related]
34. Metal-Coordinated Supramolecular Self-Assemblies for Cancer Theranostics.
Xu J; Wang J; Ye J; Jiao J; Liu Z; Zhao C; Li B; Fu Y
Adv Sci (Weinh); 2021 Aug; 8(16):e2101101. PubMed ID: 34145984
[TBL] [Abstract][Full Text] [Related]
35. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines.
Blass E; Ott PA
Nat Rev Clin Oncol; 2021 Apr; 18(4):215-229. PubMed ID: 33473220
[TBL] [Abstract][Full Text] [Related]
36. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.
Xu J; Lv J; Zhuang Q; Yang Z; Cao Z; Xu L; Pei P; Wang C; Wu H; Dong Z; Chao Y; Wang C; Yang K; Peng R; Cheng Y; Liu Z
Nat Nanotechnol; 2020 Dec; 15(12):1043-1052. PubMed ID: 33139933
[TBL] [Abstract][Full Text] [Related]
37. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Ott PA; Hu-Lieskovan S; Chmielowski B; Govindan R; Naing A; Bhardwaj N; Margolin K; Awad MM; Hellmann MD; Lin JJ; Friedlander T; Bushway ME; Balogh KN; Sciuto TE; Kohler V; Turnbull SJ; Besada R; Curran RR; Trapp B; Scherer J; Poran A; Harjanto D; Barthelme D; Ting YS; Dong JZ; Ware Y; Huang Y; Huang Z; Wanamaker A; Cleary LD; Moles MA; Manson K; Greshock J; Khondker ZS; Fritsch E; Rooney MS; DeMario M; Gaynor RB; Srinivasan L
Cell; 2020 Oct; 183(2):347-362.e24. PubMed ID: 33064988
[TBL] [Abstract][Full Text] [Related]
38. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
39. A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer.
Ni Q; Zhang F; Liu Y; Wang Z; Yu G; Liang B; Niu G; Su T; Zhu G; Lu G; Zhang L; Chen X
Sci Adv; 2020 Mar; 6(12):eaaw6071. PubMed ID: 32206706
[TBL] [Abstract][Full Text] [Related]
40. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
Martin JD; Cabral H; Stylianopoulos T; Jain RK
Nat Rev Clin Oncol; 2020 Apr; 17(4):251-266. PubMed ID: 32034288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]